Posts Tagged ‘adjuvant radiation therapy’

URO TODAY: One in five men have a DNA variation that increases the risk of prostate cancer recurring after surgery, even though other factors (early diagnosis, low aggression, etc) may be in their favour. READ MORE> and HERE>

Department of Radiation Oncology, Vanderbilt University, Nashville, US:
The A/G genotype of rs10895304 is predictive of decreased recurrence-free survival in patients with clinically localised prostate cancer.

Our data suggest that for this subset of patients, prostatectomy alone may not be adequate for local control.

This is a novel and relevant marker that should be evaluated for improved risk stratification of patients who may be candidates for adjuvant radiation therapy to improve local control.

Read Full Post »

URO TODAY: Prostate cancer patients with localised disease but positive margins do derive a survival benefit from adjuvant radiation therapy, a new study has found. READ MORE>

Read Full Post »

JUNE 3: NEW PROSTATE CANCER INFO-LINK: The role of adjuvant radiation therapy (ART) after prostatectomy in patients with adverse pathological risk factors before biochemical or clinical recurrence is still unclear. Researchers state that, in their opinions, evidence in support of using ART is evolving based on long-term follow-up data from several long-term prospective trials. READ MORE>

Read Full Post »